Acorda Therapeutics Inc (ACOR:NASDAQ)- Scopia Capital Management 16.5% stake owner. Wrote to the board urging review strategic alternative, including sales. https://finance.yahoo.com/news/activists-gonna-activate-hedge-funds-184154748.html Fibrogen Inc (FGEN:NASDAQ)- FibroGen Announces Positive Topline Results from Phase 2 Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis https://finance.yahoo.com/news/fibrogen-announces-positive-topline-results-205050467.html Charts: Thanks for reading. ~PT365
Twilio Inc (TWLO:NYSE) earning reports: Q3 EPS (5c) vs (11c) est, revenue $95.9M vs $87.6M est. Sees FY17 EPS (24c)-(22c) vs (29c), revenue $371m-375m vs 359.8M est On May 10, 2017 , CEO Jeff Lawson bought 100,000 at $23.43 for value $2,343,180 https://www.sec.gov/Archives/edgar/data/1447669/000112760217017754/xslF345X03/form4.xml Thanks for reading. ~PT365
Medicines CO (MDCO:NASDAQ)- Pending data TANGO 2 Phase 3 trial expect result available end of Q3 '17 http://www.themedicinescompany.com/investors/news/medicines-company-reports-first-quarter-2017-financial-results Company 2Q earning result will be on August 9, 2017 2. Zynerba Pharmaceuticals Inc (ZYNE:NASDAQ)- "Top-line Phase 2 results for STAR 1 trial in epilepsy and STOP trial in osteoarthritis remain on track for reporting [...]
AMD, X. The bulls are coming: These two stocks with earning reports beat. public Idea to watch. 7.25.17
Stock and Macro calendar http://www.precisiontrade365.com/stock-and-macro-calendar/ Advanced Micro Devices, Inc (AMD:NASDAQ). Earning reports Q2 EPS 2c vs 0c est. Revenue $1.22B vs $1.16B est. Stock advance +8.43% to $15.30 after hours trading. Here a look at chart Technical United States Steel Corp (X:NYSE). Q2 earning reports: EPS $1.48 vs 34c, revenue $3.14B vs $2.96B. After [...]
Earning calendar http://www.precisiontrade365.com/stock-and-macro-calendar/ "back in 2000, Reed Hastings approached former Blockbuster CEO John Antioco and asked for $50 million to give away the company he founded — Netflix." Via Businessinsider.com http://www.businessinsider.com/blockbuster-ceo-passed-up-chance-to-buy-netflix-for-50-million-2015-7 #NFLX Market Cap (MC) as of 7/17/2017 closed worth $69.693B Anyone still see Blockbuster around today? I'd say that was #EpicFail Congrats to all longs. Thanks [...]
Earning calendar http://www.precisiontrade365.com/stock-and-macro-calendar/ AMGN press released https://finance.yahoo.com/news/second-phase-3-study-shows-200000798.html KYPROLIS, Lenalidomide and Dexamethasone Reduced the Risk of Death by 21 Percent Versus Lenalidomide and Dexamethasone Patients Treated With the KYPROLIS-Based Regimen Survived 7.9 Months Longer Than Patients on Lenalidomide and Dexamethasone KYPROLIS-Based Regimens Are the First and Only to Demonstrate Improved Overall Survival Versus Today's Standards of [...]
This chart was sending out to member on Sunday for next legs breakout. It was on our biotech swing trade We locked in profits today.
Last Thursday we swing on weeklies options and noted to members to do July and August monthly call. This is the chart share to member yesterday. Price Target $155 achieved today.
Visit the Stock and Macro calendar for all events http://www.precisiontrade365.com/stock-and-macro-calendar/ These are ideas only: OCUL PDUFA July 19, second attempt. PBYI PDUFA July 21. On May 24, 2017 Puma Biotechnology Receives FDA-Advisory Committee support for Neratinib, voted 12-4 to recommened approval of PB272 http://www.pumabiotechnology.com/pr20170524.html DVAX Advisory committee review on July 28. Third attempt. Charts ideas: [...]
FDA approved BEVYXXA https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208383 Full prescribing information https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208383s000lbl.pdf